详细信息
背景信息
What is this antibody validated in? Anti-HuR / ELAVL1 antibody [EPR17397] (ab200342) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples. What is the molecular weight of HuR / ELAVL1? Anti-HuR / ELAVL1 [EPR17397] (ab200342) specifically detects a band for HuR / ELAVL1 (UniProt: Q15717) at a molecular weight of 36kDa. Trusted by the scientific community Anti-HuR / ELAVL1 [EPR17397] (ab200342) was first used in a scientific publication in 2015 and has been cited over 50 times in peer-reviewed journals. Specificity confirmed The specificity of Anti-HuR / ELAVL1 antibody [EPR17397] (ab200342) has been confirmed by Western blot testing in ELAVL1 Knockout HAP1 cells. Other related products We have a range of other formats of antibody clone [EPR17397] also available for your convenience: ab200342, Alexa Fluor® 647 - ab209609, Carrier free - ab242410, APC - ab310841, PE - ab310913, Alexa Fluor® 488 - ab310967, Alexa Fluor® 594 - ab311680, Alexa Fluor® 568 - ab312955, Alexa Fluor® 555 - ab313164, Alexa Fluor® 750 - ab321346 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.
文献引用 (95)
Targeting WTAP/ROR1/WNT5A-Mediated Crosstalk Between Glioma Stem Cells and Macrophages to Normalize Tumor Vasculature and Enhance Chemotherapy.
靶向 WTAP/ROR1/WNT5A 介导的胶质瘤干细胞与巨噬细胞之间的串扰,以使肿瘤血管正常化并增强化疗效果。
MALAT1 regulates human macrophage metabolism by interacting with HADHB
MALAT1通过与HADHB相互作用来调节人巨噬细胞代谢。
m6A Modification of ATOX1 Inhibits Acute Myeloid Leukemia Progression by Promoting Cuproptosis.
m6A修饰ATOX1通过促进铜凋亡抑制急性髓系白血病进展。
LncRNA RNF144A-AS1 increases P300-mediated H4K5 acetylation of PDE4 to promote keloid fibrosis.
LncRNA RNF144A-AS1 增加 P300 介导的 PDE4 的 H4K5 乙酰化,从而促进瘢痕疙瘩纤维化。
Human Breast Milk-Derived Exosomal FP671120.4 Inhibits Macrophage M1 Polarization via Modulating the ELAVL1/Nrf2 Axis in Sepsis-Associated Liver Injury.
人乳来源的外泌体 FP671120.4 通过调节脓毒症相关肝损伤中的 ELAVL1/Nrf2 轴抑制巨噬细胞 M1 极化。
Mechanistic insights into the role of EGLN3 in pulmonary vascular remodeling and endothelial dysfunction
EGLN3 在肺血管重塑和内皮功能障碍中的作用机制见解
Inhibition of HuR/ELAVL-1 attenuates fibrotic progression in Mdx mice with dilated cardiomyopathy.
抑制 HuR/ELAVL-1 可减轻 Mdx 扩张型心肌病小鼠的纤维化进展。
HuR Knockdown in MLO-Y4 Osteocyte-like Cells Elevates OPG Expression and Suppresses Osteoclastogenesis In Vitro.
在 MLO-Y4 骨细胞样细胞中敲低 HuR 可提高 OPG 表达并抑制体外破骨细胞生成。
Loss of the RNA Binding Protein HuR in Early Murine Limb Mesenchyme Does Not Affect Development but Leads to Impaired Bone Homeostasis in Adulthood.
小鼠早期肢体间充质中 RNA 结合蛋白 HuR 的缺失不会影响发育,但会导致成年期骨骼稳态受损。
HuR inhibition reduces post-ischemic cardiac remodeling by dampening myocyte-dependent inflammatory gene expression and the innate immune response.
HuR 抑制通过减弱心肌细胞依赖性炎症基因表达和先天免疫反应来减少缺血后心脏重塑
- 1
- 2
- 3
- 4
- 5
- 6
- 10